Sage Therapeutics Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	2016 - 2020
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021	2016 - 2020
Net Income	14.74	18.38	-0.37	-2.33	1.41	Upgrade
Depreciation & Amortization	8.05	-	-	-	-	Upgrade
Other Operating Activities	16.11	2.41	0.52	0.44	-1.58	Upgrade
Change in Accounts Receivable	-533.82	-347.09	-1.71	-	-	Upgrade
Change in Inventory	-34.07	175.21	-	-	-	Upgrade
Change in Accounts Payable	141.81	99.39	0.07	0.03	-0.25	Upgrade
Change in Other Net Operating Assets	-475.33	-24.15	0.02	0.09	-0.15	Upgrade
Operating Cash Flow	-862.52	-75.85	-1.46	-1.77	-0.57	Upgrade
Capital Expenditures	-59.87	-3.03	-	-	-	Upgrade
Investment in Securities	-1,201	-309	-	-	-	Upgrade
Other Investing Activities	7.72	-0	-	-	-	Upgrade
Investing Cash Flow	-1,254	-312.04	-	-	-	Upgrade
Long-Term Debt Issued	598.79	-	1.68	1.49	-	Upgrade
Long-Term Debt Repaid	-	-11.76	-	-	-	Upgrade
Net Debt Issued (Repaid)	598.79	-11.76	1.68	1.49	-	Upgrade
Issuance of Common Stock	396.51	382.6	-	-	-	Upgrade
Other Financing Activities	2,154	0.24	-0.02	-0.01	-0.01	Upgrade
Financing Cash Flow	3,149	371.08	1.66	1.48	-0.01	Upgrade
Miscellaneous Cash Flow Adjustments	0.05	25.93	0	-	-	Upgrade
Net Cash Flow	1,033	9.13	0.2	-0.29	-0.59	Upgrade
Free Cash Flow	-922.39	-78.88	-1.46	-1.77	-0.57	Upgrade
Free Cash Flow Margin	-82.22%	-37.59%	-81.28%	-	-34.73%	Upgrade
Free Cash Flow Per Share	-13.77	-4.66	-8.48	-10.29	-3.33	Upgrade
Cash Interest Paid	2.97	-	-	-	-	Upgrade
Cash Income Tax Paid	9.23	0.49	0.02	0.01	0.01	Upgrade
Levered Free Cash Flow	-547.11	-281.86	-1.62	-1.12	-0.62	Upgrade
Unlevered Free Cash Flow	-544.19	-281.43	-1.52	-1.06	-0.51	Upgrade
Change in Net Working Capital	512.22	288.89	1.61	-0.12	0.4	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.